A detailed history of Eastern Bank transactions in Biogen Inc. stock. As of the latest transaction made, Eastern Bank holds 924 shares of BIIB stock, worth $160,581. This represents 0.0% of its overall portfolio holdings.

Number of Shares
924
Holding current value
$160,581
% of portfolio
0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$189.07 - $236.8 $174,700 - $218,803
924 New
924 $179,000
Q4 2021

Jan 26, 2022

SELL
$223.92 - $287.77 $170,179 - $218,705
-760 Closed
0 $0
Q3 2021

Oct 19, 2021

SELL
$282.99 - $369.05 $22,639 - $29,524
-80 Reduced 9.52%
760 $216,000
Q1 2021

Apr 27, 2021

SELL
$242.95 - $284.63 $4,373 - $5,123
-18 Reduced 2.1%
840 $235,000
Q3 2020

Oct 30, 2020

SELL
$264.77 - $305.71 $12,179 - $14,062
-46 Reduced 5.09%
858 $244,000
Q2 2020

Jul 21, 2020

SELL
$258.66 - $342.55 $178,216 - $236,016
-689 Reduced 43.25%
904 $241,000
Q1 2020

Apr 27, 2020

BUY
$268.85 - $341.04 $102,969 - $130,618
383 Added 31.65%
1,593 $504,000
Q3 2019

Nov 04, 2019

SELL
$217.44 - $243.88 $14,351 - $16,096
-66 Reduced 5.17%
1,210 $282,000
Q2 2019

Jul 24, 2019

SELL
$219.29 - $241.72 $12,060 - $13,294
-55 Reduced 4.13%
1,276 $298,000
Q1 2019

Apr 18, 2019

SELL
$216.71 - $338.96 $18,637 - $29,150
-86 Reduced 6.07%
1,331 $314,000
Q4 2018

Jan 18, 2019

SELL
$278.5 - $352.75 $4,734 - $5,996
-17 Reduced 1.19%
1,417 $426,000
Q3 2018

Oct 16, 2018

SELL
$293.51 - $383.83 $34,927 - $45,675
-119 Reduced 7.66%
1,434 $506,000
Q1 2018

Apr 09, 2018

SELL
$260.13 - $367.91 $11,965 - $16,923
-46 Reduced 2.88%
1,553 $424,000
Q4 2017

Jan 22, 2018

SELL
$307.64 - $344.58 $55,990 - $62,713
-182 Reduced 10.22%
1,599 $510,000
Q3 2017

Oct 24, 2017

BUY
$281.15 - $329.69 $500,728 - $587,177
1,781
1,781 $558,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Eastern Bank Portfolio

Follow Eastern Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eastern Bank, based on Form 13F filings with the SEC.

News

Stay updated on Eastern Bank with notifications on news.